Prevalence of celiac disease in systemic lupus erythematosus, sjogren syndrome and systemic sclerosis: A systematic review and meta-analysis
Digestive and Liver Disease · 2024
DOI: 10.1016/j.dld.2024.03.015 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Digestive and Liver Disease, 2024. Verfasst von Renato Beas und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA. Electronic address: renatobeas@gmail.com. Hauptthemen laut MEDLINE: Celiac Disease, Lupus Erythematosus, Systemic, Scleroderma, Systemic, Sjogren's Syndrome. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Celiac disease (CeD) is an immune-mediated disorder affecting the small bowel, associated with genetic factors and increasing global prevalence. AIM: This study explores the association between CeD, Systemic Lupus Erythematosus (SLE), primary Sjogren syndrome (pSS), and Systemic Sclerosis (SSc). METHODS: A systematic review and meta-analysis were conducted following PRISMA guidelines. Searches across multiple databases yielded 2728 articles, with 15 studies selected. Data extraction included study characteristics, prevalence of CeD and CeD antibodies in SLE, pSS, and SSc. Quality assessment utilized the Newcastle-Ottawa Scale. RESULTS: The meta-analysis revealed a pooled prevalence of biopsy-proven CeD in SLE, pSS, and SSc of approximately 3%. Seroprevalence of any CeD antibody in SLE, pSS, and SSc ranged from 3% to 10%. Notably, pSS exhibited the highest prevalence at 5.59%. High heterogeneity was observed in seroprevalence across autoimmune conditions. Quality assessment indicated robust methodological quality in the selected studies. CONCLUSION: This study highlights a significantly higher prevalence of CeD, especially pSS, compared to the general population. The findings underscore the importance of recognizing elevated CeD antibodies in patients with SLE, pSS and SSc emphasizing the need for early detection and comprehensive care for gastrointestinal symptoms in these conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA. Electronic address: renatobeas@gmail.com.
- Universidad Nacional de San Agustín de Arequipa, Arequipa, Peru.
- Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
- Division of Preventive Medicine, Department of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.
- Escuela de Medicina, Universidad Peruana de Ciencias Aplicadas, Lima, Peru.
- Ruth Lilly Medical Library, Indiana University School of Medicine, Indianapolis, IN, USA.
Zitieren
APA
Beas, R., Altamirano-Farfan, E., Izquierdo-Veraza, D., Norwood, D. A., Riva-Moscoso, A., Godoy, A., Montalvan-Sanchez, E. E., Ramirez, M., Guifarro, D. A., Kitchin, E., Fischer, M., & Kurada, S. (2024). Prevalence of celiac disease in systemic lupus erythematosus, sjogren syndrome and systemic sclerosis: A systematic review and meta-analysis. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2024.03.015
Vancouver
Beas R, Altamirano-Farfan E, Izquierdo-Veraza D, Norwood DA, Riva-Moscoso A, Godoy A, et al. Prevalence of celiac disease in systemic lupus erythematosus, sjogren syndrome and systemic sclerosis: A systematic review and meta-analysis. Digestive and Liver Disease. 2024. doi:10.1016/j.dld.2024.03.015
BibTeX
@article{Beas2024,
author = {Beas, Renato and Altamirano-Farfan, Euler and Izquierdo-Veraza, Diego and Norwood, Dalton A and Riva-Moscoso, Adrian and Godoy, Ambar and Montalvan-Sanchez, Eleazar E and Ramirez, Mirian and Guifarro, Daniel A and Kitchin, Emily and Fischer, Monika and Kurada, Satya},
title = {Prevalence of celiac disease in systemic lupus erythematosus, sjogren syndrome and systemic sclerosis: A systematic review and meta-analysis},
journal = {Digestive and Liver Disease},
year = {2024},
doi = {10.1016/j.dld.2024.03.015}
}
EUVIMED